Nano Labs Ltd Announces Entry Into At The Market Offering Agreement

About this update from Nano Labs Ltd

[{"type":"text","content":"HONG KONG, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, announced that it has entered into an At The Market Offering Agreement (the “Sales Agreement”) with Maxim Group LLC as sole sales agent to sell its shares of Class A Ordinary Shares par value $0.002 per share (the “Class A Ordinary Share” or the “Shares”), from time to time in an at the market offering (the “Offering”). Pursuant to the Prospectus Supplement (as defined below) and accompanying base prospectus, we may offer and sell the Class A Ordinary Shares from time to time under the Sales Agreement having an aggregate offering price of up to $45,000,000 in the Offering. Nano Labs currently intends to use the net proceeds from the sale of the Class A Ordinary Shares offered by the Company (if any) under the Sales Agreement primarily for BNB and crypto asset reserve strategy, research and development of new products and general corporate purposes and working capital. The sales, if any, of the Class A Ordinary Shares made in the Offering will be made by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), including sales made directly on or through the Nasdaq Capital Market (the “Nasdaq”) or any other existing trading market for the Class A Common Stock. The Offering will be made only by means of a prospectus supplement, filed with the U.S. Securities and Exchange Commission (the “SEC”) on August 21, 2025 (the “Prospectus Supplement”), together with the accompanying base prospectus contained therein, which Prospectus Supplement forms a part of the Company’s shelf registration statement on Form F-3 (File No. 333-273968) (the “Registration Statement”), which was declared effective by the SEC on September 1, 2023. Electronic copies of the Prospectus Supplement and accompanying base prospectus may be obtained on the SEC’s website at www.sec.gov or by contacting Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022 at [email protected]. This press release does not constitute an offer to sell or the solicitation of an offer to buy the Class A Ordinary Shares discussed herein, nor shall there be any sale of such shares in any...

More updates from Nano Labs Ltd